Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 181 (6) , 1365-1373
- https://doi.org/10.1016/s0002-9378(99)70377-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Hormone replacement therapy and cardioprotection: basic concepts and clinical considerationsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
- Identification of Authentic Estrogen Receptor in Cultured Endothelial CellsCirculation, 1996
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Estrogen replacement therapy and strokeProgress in Cardiovascular Diseases, 1995
- Postmenopausal oestrogens and arteriesBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapyFertility and Sterility, 1994
- Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer's Disease: A Population-based Case-Control StudyAmerican Journal of Epidemiology, 1994
- Cardiovascular protection by oestrogen—a calcium antagonist effect?The Lancet, 1993
- Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal womenFertility and Sterility, 1992